Not responding to you specifically, Creek. From the 1:20 dividend, through the NGIO spin off, and this final dividend with retired shares, nothing has gone smoothly. In between us and our windfall are MM's, transfer agents, and on-line brokers (some good, others not so good), not to mention we are still OTC. Joe and mgmt. are doing things that just aren't done often, if they are done at all. There are so many moving parts, we have no choice but to be patient. IMO, that's why volume has been relatively low and there appears to be little excitement, except what we generate on this board. If it seems to good to be true, it often is. That's the way the stock market goes. I bought Allergan because Pfizer was going to buy them out. Easy money, right? Wrong! The FTC had other ideas. Let the smoke clear and give mgmt. a chance to make their calls and pull their strings. It's going to take time. There will be more ups and downs and temporary disappointments. Our boys have done right by us to date, so they deserve the benefit of the doubt. On to NASDAQ even if we see a drop in the pps. Until then we have to wait for the clarifying PR's as we've been receiving all along.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links